GlassScriptPhysician profile
Laura Rodriguez
NPI 1174642763
$15,434.70
in general payments reported to CMS, 2019-2025
38 companies · $1,849 in 2025
The $1,849 reported for 2025 was more than what 94% of Critical Care Medicine (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $203).
See the full distribution for Critical Care Medicine (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $720 · 2022: $4,019 · 2023: $6,003 · 2024: $2,844 · 2025: $1,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,425 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,250 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,425.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,250.00 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,549.42 | 2021-2025 | Lifevest |
| Abiomed | $1,464.93 | 2023-2025 | Impella |
| Medtronic, INC. | $1,115.34 | 2021-2024 | Endurant Iis |
| Novartis Pharmaceuticals Corporation | $941.30 | 2023-2025 | |
| Endotronix, INC. | $471.73 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Saranas, INC. | $245.17 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $241.44 | 2021-2025 | Verquvo |
| Cvrx, INC. | $198.40 | 2023-2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $195.70 | 2021-2025 | |
| Scpharmaceuticals INC. | $185.85 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $181.44 | 2021-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $136.62 | 2021-2025 | Onpattro, Amvuttra |
| Pfizer INC. | $120.47 | 2022-2025 | |
| Cardiovascular Systems INC. | $120.44 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $118.54 | 2021-2025 | Camzyos, Eliquis |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $110.88 | 2025 | Perclose Prostyle, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Zoll Circulation INC | $100.00 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Itamar Medical INC | $83.77 | 2022-2023 | Watchpatone |
| Astrazeneca Pharmaceuticals LP | $75.31 | 2021-2025 | Wainua |
| Novo Nordisk INC | $73.06 | 2025 | Wegovy |
| Boston Scientific Corporation | $72.16 | 2024-2025 | Watchman Flx |
| Chiesi USA, INC. | $65.18 | 2022-2025 | Kengreal, Cleviprex |
| Lexicon Pharmaceuticals, INC. | $64.44 | 2023-2024 | Inpefa |
| Amgen INC. | $54.79 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $51.74 | 2021 | |
| Esperion Therapeutics, INC. | $51.61 | 2021 | |
| Atricure, INC. | $42.50 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.35 | 2021 | |
| Astellas Pharma US INC | $36.81 | 2021 | |
| W. L. Gore & Associates, INC. | $34.28 | 2022 | |
| Medicomp INC | $33.86 | 2024 | Telepatch Cardiac Monitor |
| Cordis US Corp. | $33.78 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Shockwave Medical, INC | $25.31 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Vifor Pharma, INC. | $24.72 | 2021 | |
| Heartflow, INC. | $23.03 | 2025 | |
| Emd Serono, INC. | $21.43 | 2021 | |
| Angiodynamics, INC. | $18.55 | 2021 | |
| Amryt Pharma Holdings LTD | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.